TABLE 1

Demographics for hepatocyte donors used in the HepatoPac model

DemographicsDonor 1Donor 2aDonor 3bDonor 4cDonor 5d
GenderFemaleMaleFemaleFemaleMale
Age1956546131
Race/EthnicityCaucasianAfrican AmericanCaucasianNot providedCaucasian
Cause of deathIntracerebral bleed secondary to Intracranial hemorrhage/strokeCerebrovascular accident Anoxia secondary to cerebrovascular accidentNot providedAnoxia, secondary to heroin overdose
Medical historyLupusDiabetes, hypertension, kidney disease, insulinDiabetes and hypertension, 3 years, med compliantNot providedAsthma: allergy-induced
Social historyNo alcohol, tobacco, or drug useNo alcohol, tobacco, or drug useNonsmoker, social drinkerNot providedEthanol, tobacco, marijuana, oxycontin, heroin
  • a This donor was determined through genotyping analysis to be CYP3A5 *1*3.

  • b This donor was determined through genotyping analysis to be CYP3A5 *3*3.

  • c This donor was designated as RTM by the manufacturer.

  • d This donor was designated as donor 1307 by the manufacturer and was determined through genotyping analysis to be CYP3A5 *3*3.